HK1134136A1 - Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging - Google Patents

Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging

Info

Publication number
HK1134136A1
HK1134136A1 HK10101213.7A HK10101213A HK1134136A1 HK 1134136 A1 HK1134136 A1 HK 1134136A1 HK 10101213 A HK10101213 A HK 10101213A HK 1134136 A1 HK1134136 A1 HK 1134136A1
Authority
HK
Hong Kong
Prior art keywords
aging
diagnosis
methods
risk assessment
mediated diseases
Prior art date
Application number
HK10101213.7A
Other languages
English (en)
Inventor
Dayan Goodenowe
Original Assignee
Phenomenome Discoveries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phenomenome Discoveries Inc filed Critical Phenomenome Discoveries Inc
Publication of HK1134136A1 publication Critical patent/HK1134136A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/0027—Methods for using particle spectrometers
    • H01J49/0031—Step by step routines describing the use of the apparatus
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/26—Mass spectrometers or separator tubes
    • H01J49/34—Dynamic spectrometers
    • H01J49/36—Radio frequency spectrometers, e.g. Bennett-type spectrometers, Redhead-type spectrometers
    • H01J49/38—Omegatrons ; using ion cyclotron resonance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7042—Aging, e.g. cellular aging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Ecology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK10101213.7A 2007-04-13 2010-02-04 Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging HK1134136A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91154807P 2007-04-13 2007-04-13
PCT/CA2008/000659 WO2008124916A1 (fr) 2007-04-13 2008-04-09 Procédés pour le diagnostic et l'évaluation de risque de maladies dues au vieillissement induites par la déficience en plasmalogène

Publications (1)

Publication Number Publication Date
HK1134136A1 true HK1134136A1 (en) 2010-04-16

Family

ID=39863191

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10101213.7A HK1134136A1 (en) 2007-04-13 2010-02-04 Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging

Country Status (8)

Country Link
US (2) US20100105101A1 (fr)
EP (1) EP2145181B1 (fr)
JP (1) JP5220842B2 (fr)
CN (1) CN101675337A (fr)
AU (1) AU2008238553B2 (fr)
CA (1) CA2680748C (fr)
HK (1) HK1134136A1 (fr)
WO (1) WO2008124916A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI475989B (zh) 2008-12-22 2015-03-11 Phenomenome Discoveries Inc 縮醛磷脂類化合物，含彼之醫藥組成物以及治療老化疾病的方法
US20110275600A1 (en) * 2009-01-02 2011-11-10 Frederic Destaillats Methods for increasing endogenous plasmalogen levels
JP2012519199A (ja) 2009-03-04 2012-08-23 ネステク ソシエテ アノニム 哺乳動物における内因性プラスマローゲンレベルを上昇させる方法
EP2483697B2 (fr) 2009-10-01 2017-07-05 Phenomenome Discoveries Inc. Méthode pour diagnostiquer le cancer du pancréas
JP6025568B2 (ja) * 2010-12-28 2016-11-16 株式会社藤野ブレインリサーチ 認知症を血液サンプルで判定するための検査方法
US20140051105A1 (en) * 2011-01-17 2014-02-20 The Johns Hopkins University Mutant Proteins as Cancer-Specific Biomarkers
AU2018255514A1 (en) * 2017-04-17 2019-10-17 Med-Life Discoveries Lp Cyclic plasmenylethanolamines
CN115515600B (zh) * 2020-04-28 2024-06-25 株式会社流变机能食品研究所 免疫功能兴奋用组合物
CN113244246B (zh) * 2021-05-11 2022-05-06 江南大学 一种微生物源缩醛磷脂在治疗结肠癌中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009371A1 (fr) * 1992-10-09 1994-04-28 Massachusetts Institute Of Technology Test diagnostique ante mortem pour la detection de la maladie d'alzheimer
US5731354A (en) * 1996-05-06 1998-03-24 Clarion Pharmaceuticals Inc. Treatment for the inhibition of neuro-degenerative disease states
DE19836617C2 (de) * 1998-08-12 2001-02-08 Ulrich Frei In vitro Verfahren zur Erkennung und Diagnostik akuter koronarer Syndrome
US6177476B1 (en) * 1998-08-27 2001-01-23 Clarion Pharmaceuticals Inc. Nutritional supplements for replenishing plasmalogens
KR20010102069A (ko) * 1999-02-11 2001-11-15 추후제출 고효율 질량 분석
CA2298181C (fr) * 2000-02-02 2006-09-19 Dayan Burke Goodnough Analyse d'echantillons complexes non-cibles
CA2299210A1 (fr) * 2000-02-17 2001-08-17 Gregory R. Wade Une methode pour evaluer la situation biologique du developpement d'un cancer
WO2005085838A2 (fr) 2004-03-02 2005-09-15 Vanderbilt University Analyse computationnelle de matrices en lipidomique a spectroscopie de masse
JP4176749B2 (ja) * 2005-07-29 2008-11-05 学校法人帝京大学 疾病検査法
US20080020472A1 (en) * 2005-11-22 2008-01-24 Frantz Biomarkers, Llc Method for detecting an inflammatory disease or cancer
US7491504B2 (en) * 2005-11-22 2009-02-17 Frantz Biomarkers, Llc Method for detecting ovarian cancer
WO2007098585A1 (fr) * 2006-02-28 2007-09-07 Phenomenome Discoveries Inc. Méthodes permettant de diagnostiquer la démence et autres troubles neurologiques

Also Published As

Publication number Publication date
US20160320366A1 (en) 2016-11-03
WO2008124916A1 (fr) 2008-10-23
JP2010523986A (ja) 2010-07-15
US10302624B2 (en) 2019-05-28
AU2008238553B2 (en) 2014-06-19
JP5220842B2 (ja) 2013-06-26
CN101675337A (zh) 2010-03-17
WO2008124916A8 (fr) 2009-01-15
AU2008238553A1 (en) 2008-10-23
EP2145181A4 (fr) 2011-01-12
EP2145181B1 (fr) 2012-12-26
CA2680748A1 (fr) 2008-10-23
CA2680748C (fr) 2012-08-28
US20100105101A1 (en) 2010-04-29
EP2145181A1 (fr) 2010-01-20

Similar Documents

Publication Publication Date Title
HK1134136A1 (en) Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging
HK1250392A1 (zh) 子癇前期檢測和治療的方法和組合物
IL207360A0 (en) Methods of diagnosing and treating parp - mediated diseases
HK1202558A1 (en) Compositions and methods for the therapy and diagnosis of influenza
GB2474146B (en) Methods of determining the health status of an individual
EP2265731A4 (fr) Procédés et composition pour évaluer la réponse aux médicaments
EP2444491B1 (fr) Facteur IX de coagulation humain hyperglycosylé
HK1158635A1 (en) Novel compounds useful for the treatment of degenerative and inflammatory diseases
HK1146894A1 (en) Compositions and methods for treating diseases of the nail
EP2361089A4 (fr) Compositions et procédés pour le traitement d une fonction altérée de l' -synucléine
EP2347256A4 (fr) Utilisation et identification de biomarqueurs pour les maladies gastro-intestinales
PT2614832T (pt) Diagnóstico de pré-eclâmpsia
EP2288365A4 (fr) Facteurs de coagulation ciblés et procédés d'utilisation de ceux-ci
GB0808711D0 (en) Tissue assessment
EP2389104A4 (fr) Identification du niveau de risque foetal pendant le travail
IL192319A0 (en) Assessment of medical conditions
EP2225559B8 (fr) Evaluation d'états physiologiques
EP2173166A4 (fr) Inhibiteurs de l'acide polysialique de-n-acétylase et procédés pour leur utilisation
EP2208986A4 (fr) Procédé de détermination de l'auto-inducteur 2
HUP1100131A3 (en) Diagnosis of systemic diseases
EP2334813A4 (fr) Procédés et kits pour le diagnostic des maladies associées à ryr1
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia
PL383160A1 (pl) Sposób i układ elektrod do pomiaru właściwości elektrycznych tkanek
PL383745A1 (pl) Metoda oceny stanu aparatu ruchu człowieka
AU2008906405A0 (en) Diagnostic and therapeutic methods